IEEE Access (Jan 2023)
Brain Tumor Classification Using Hybrid Single Image Super-Resolution Technique With ResNext101_32× 8d and VGG19 Pre-Trained Models
Abstract
High-quality images acquired from medical devices can be utilized to aid diagnosis and detection of various diseases. However, such images can be very expensive to acquire and difficult to store, and the process of diagnosis can consume significant time. Automatic diagnosis based on artificial intelligence (AI) techniques can contribute significantly to overcoming the cost and time issues. Pre-trained deep learning models can present an effective solution to medical image classification. In this paper, we propose two such models, ResNext101_ $32\times 8\text{d}$ and VGG19 to classify two types of brain tumor: pituitary and glioma The proposed models are applied to a dataset consisting of 1,800 MRI images comprising in two classes of diagnoses; glioma tumor and pituitary tumor. A single-image super-resolution (SISR) technique is applied to the MRI images to classify and enhance their basic features, enabling the proposed models to enhance particular aspects of the MRI images and assist the training process of the models. These models are implemented using PyTorch and TensorFlow frameworks with hyper-parameter tuning, and data augmentation. Experimentally, receiver operating characteristic curve (ROCC), the error matrix, Precision, and Recall are used to analyze the performance of the proposed model. Results obtained demonstrate that VGG19 and ResNext101_ $32\times 8\text{d}$ achieved testing accuracies of 99.98% and 100%, and loss rates of 0.0120 and 0.108, respectively. The F1-score, Precision, Recall, and the area under the ROC for VGG19 were 99.89%, 99.90%, 99.89%, and 100%, respectively, while for the ResNext101_ $32\times 8\text{d}$ they were all 100%. The proposed models when applied to MRI images to provide a quick and accurate approach to distinguishing between patients with pituitary and glioma tumors, and could aid doctors and radiologists in the screening of patients with brain tumors.
Keywords